Pharma’s Latest Challenge: What To Do About New Provider-Payer Business Models
Even though their specifics are not widely known, the concepts of Medicare's accountable care organizations and other payer-provider linkups are spurring change in the pharmaceutical industry's commercial landscape.
You may also be interested in...
CMS officials are acknowledging the challenges health care industry stakeholders face in embracing accountable care organizations while federal regulations governing the program are still in flux.
Feisty Amarin is certainly undergoing a reincarnation.
ACOs have been one of the most hyped innovations in the US health care sector this decade. The buzz may be overdone, but ACOs are now established as a different—and confusing—new customer segment for pharma. How is industry adjusting?